Fisher & Paykel Healthcare Co Ltd 2019 AR2
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2019, marking its 50th anniversary. The company achieved a milestone of NZ$1.07 billion in operating revenue, representing a 9% increase, with net profit after tax rising 10% to NZ$209.2 million. Key product developments included the launch of the F&P Vitera full face mask and neonatal breathing circuits for the F&P 950 system. On the sustainability front, the company reduced its carbon emission intensity to 37.2 tCO2e/NZ$M in FY18 and maintained a 69% recycling rate at its New Zealand campus.
Company: Fisher & Paykel Healthcare Co Ltd
Sector: Manufacturing
Country: New Zealand
Year: 2019
Type: AR2
Pages: 108
Fisher & Paykel Healthcare Co Ltd
The report highlights Fisher & Paykel Healthcare's financial and sustainability performance for the fiscal year ended March 31, 2019, marking its 50th anniversary. The company achieved a milestone of NZ$1.07 billion in operating revenue, representing a 9% increase, with net profit after tax rising 10% to NZ$209.2 million. Key product developments included the launch of the F&P Vitera full face mask and neonatal breathing circuits for the F&P 950 system. On the sustainability front, the company reduced its carbon emission intensity to 37.2 tCO2e/NZ$M in FY18 and maintained a 69% recycling rate at its New Zealand campus.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees